Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05856786 · ClinicalTrials.gov registry record

To Study the Effects of Refractive Surgery on OCT Measurements in the Eye

A clinical trial of Myopia and Refractive Errors, sponsored by University of Nebraska.

Recruiting
Registry status
33
Enrollment target
1
Study location

NCT05856786: Recruiting study of Myopia and Refractive Errors, sponsored by University of Nebraska.

NCT05856786 is a study of Myopia and Refractive Errors that is actively recruiting participants, run by University of Nebraska. The registered enrollment target is 33 participants, below the 268-participant average among 90 other Myopia trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05856786, a study of Myopia and Refractive Errors, is actively recruiting participants, sponsored by University of Nebraska.

RECRUITING
Registry status
33 participants
Enrollment target
1
Study location

Study Summary

Corrective eye surgeries, such as Lasik, are widely used to correct focusing problems such as myopia, or nearsightedness. Often these patients develop other conditions like myopic maculopathy or glaucoma which require monitoring with optical coherence tomography (OCT). Since OCT is a light-based test and changes the refractive status of the eye (in the cornea or the lens), it can potentially affect the results of the OCT measurements but has not been sufficiently studied. This pilot study aims at studying the potential change in OCT parameters in the eye after undergoing such surgery.

Primary Outcome

Proportion of Change in thickness of retina and its layers measured in microns

Conditions Studied

Myopia Refractive Errors Optical Coherence Tomography

Interventions

  • DIAGNOSTIC_TEST Optical coherence tomography

Study Locations (1)

Nebraska

  • Unversity of Nebraska Medical Center - Omaha

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2024-06-01
Est. Completion 2026-12
University of Nebraska

407 total trials

What NCT05856786 shows while recruiting

NCT05856786 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 268-participant average among 90 other Myopia trials with a reported enrollment target (88% lower).

The record links to 3 conditions, with Myopia appearing as the primary indexed condition, and to 1 intervention - of which Optical coherence tomography is the first listed.

NCT05856786 reports a single indexed study location in Nebraska.

Frequently Asked Questions

What is clinical trial NCT05856786 about?

NCT05856786 is a clinical study titled "To Study the Effects of Refractive Surgery on OCT Measurements in the Eye". Corrective eye surgeries, such as Lasik, are widely used to correct focusing problems such as myopia, or nearsightedness. Often these patients develop other conditions like myopic maculopathy or glaucoma which require monitoring with optical coherence tomography (OCT). Since OCT is a light-based tes...

What is the current status of trial NCT05856786?

This trial is currently recruiting. The enrollment target is 33 participants. The study started on 2024-06-01. Estimated completion is 2026-12.

What conditions does trial NCT05856786 study?

This clinical trial studies the following conditions: Myopia, Refractive Errors, Optical Coherence Tomography.

What interventions are being tested in trial NCT05856786?

The interventions under investigation include: Optical coherence tomography (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05856786?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05856786 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05856786's enrollment target sits among peer trials

33 83rd of 90 higher than 8 of 90 other Myopia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02861898 · 33 participants · Phase 1

    Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

  • NCT04871607 · 33 participants · Phase 2

    Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma

  • NCT05071937 · 33 participants · Phase 2

    ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer

  • NCT05168618 · 33 participants · Phase 2

    Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT05856786

Source: ClinicalTrials.gov NCT05856786, the US trial registry maintained by the National Library of Medicine. NCT05856786 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.